Erratum: Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor (Cardiovasc Intervent Radiol (2011) 34 (824-832) DOI 10.1007/s00270-011-0179-x);Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor

CardioVascular and Interventional Radiology

Volumn 34, Issue 4, 2011, Pages 824-832

  Deng, Gang ^a   Zhao, Deng Ling ^a   Li, Guang Chao ^a   Yu, Hui ^a   Teng, Gao Jun ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Angiogenesis; Arterial; CT; Embolization; Immunohistology; Liver tumor; Perfusion

Indexed keywords

CD31 ANTIGEN; ENDOSTAR; EPIRUBICIN; IODINATED POPPYSEED OIL; RECOMBINANT ENDOSTATIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD VESSEL PARAMETERS; BLOOD VOLUME; CANCER CONTROL; CANCER INHIBITION; CANCER SIZE; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; HEPATIC ARTERY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MICROVASCULAR DENSITY; NONHUMAN; OUTCOME ASSESSMENT; PERFUSION COMPUTER ASSISTED TOMOGRAPHY; PERMEABILITY SURFACE AREA PRODUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RABBIT; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; VALIDATION PROCESS;

EID: 79960913670     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0274-z     Document Type: Erratum

References (40)

1. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 533 543 11905707 10.1016/S1470-2045(01)00486-7 1:STN:280:DC%2BD387ntlCrtw%3D%3D (Pubitemid 33586866)
2. JM Llovet MI Real X Montaña, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734 1739 12049862 10.1016/S0140-6736(02)08649-X (Pubitemid 34607087)
3. CM Lo H Ngan WK Tso, et al. 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 1171 11981766 10.1053/jhep.2002.33156 1:CAS:528:DC%2BD38XktF2hu7w%3D (Pubitemid 34454013)
4. L Marelli R Stigliano C Triantos, et al. 2007 Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 6 25 17103105 10.1007/s00270-006-0062-3 (Pubitemid 44900485)
5. DB Brown JF Geschwind MC Soulen SF Millward D Sacks 2006 Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies J Vasc Interv Radiol 17 217 223 16517767 10.1097/01.RVI.0000196277. 76812.A3 (Pubitemid 44341440)
6. XF Liao JL Yi XR Li W Deng ZF Yang G Tian 2004 Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization World J Gastroenterol 10 1885 1889 15222029 (Pubitemid 39029285)
7. X Li GS Feng CS Zheng CK Zhuo X Liu 2004 Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level World J Gastroenterol 10 2878 2882 15334691 1:CAS:528:DC%2BD2cXovVWntLg%3D (Pubitemid 39303010)
8. YB Kim YN Park C Park 2001 Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization Histopathology 38 160 166 11207829 10.1046/j.1365-2559.2001.01064.x 1:STN:280:DC%2BD3M3jsFCitg%3D%3D (Pubitemid 32193630)
9. S Gupta S Kobayashi S Phongkitkarun LD Broemeling Z Kan 2006 Effect of Transcatheter hepatic arterial embolization on angiogenesis in an animal model Invest Radiol 41 516 521 16763470 10.1097/01.rli.0000209663.00629.8a (Pubitemid 44284186)
10. WJ Guo J Li Z Chen, et al. 2004 Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion Hepatogastroenterology 51 381 386 15086165 1:CAS:528:DC%2BD2cXjsFenu70%3D (Pubitemid 38445280)
11. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other disease Nature 407 249 257 11001068 10.1038/35025220 1:CAS:528:DC%2BD3cXmvVSls74%3D
12. EJ Battegay 1995 Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects J Mol Med 73 333 346 8520966 10.1007/BF00192885 1:CAS:528:DyaK2MXnvVShtr8%3D
13. TK Rhee JY Young AC Larson, et al. 2007 Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1α in rabbit VX2 liver tumors JVIR 18 639 646 17494846 10.1016/j.jvir.2007.02.031 (Pubitemid 46661178)
14. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc AC de Oliveira A Santoro JL Raoul A Forner M Schwartz C Porta S Zeuzem L Bolondi TF Greten PR Galle JF Seitz I Borbath D Haussinger T Giannaris M Shan M Moscovici D Voliotis J Bruix 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 18650514 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D
15. AL Cheng YK Kang Z Chen CJ Tsao S Qin JS Kim R Luo J Feng S Ye TS Yang J Xu Y Sun H Liang J Liu J Wang WY Tak H Pan K Burock J Zou D Voliotis Z Guan 2009 Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 1 25 34 19095497 10.1016/S1470-2045(08) 70285-7 1:CAS:528:DC%2BD1cXhsFChtbnM
16. MS O'Reilly T Boehm Y Shing, et al. 1997 Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 277 285 9008168 10.1016/S0092-8674(00)81848-6 (Pubitemid 28015876)
17. F Graepler B Verbeek T Graeter, et al. 2005 Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC Hepatology 41 879 886 15739185 10.1002/hep.20613 1:CAS:528:DC%2BD2MXjsV2msbw%3D (Pubitemid 40462951)
18. J Folkman 2006 Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action Exp Cell Res 312 594 607 16376330 10.1016/j.yexcr.2005.11. 015 1:CAS:528:DC%2BD28XhvVWltbY%3D (Pubitemid 43290336)
19. F Liu G Tan J Li X Dong GW Krissansen X Sun 2007 Gene transfer of endostatin enhances the efficacy of doxorubicin to suppress human hepatocellular carcinomas in mice Cancer Sci 98 1381 1387 17627616 10.1111/j.1349-7006.2007. 00542.x 1:CAS:528:DC%2BD2sXhtVaksrrK (Pubitemid 47241760)
20. J Wang Y Sun Y Liu, et al. 2005 Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients Chin J Lung Cancer 8 283 290 10.1007/s11670-005-0027-0 (Pubitemid 41206392)
21. Y Ling Y Yang N Lu, et al. 2007 Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells Biochem Biophys Res Commun 361 79 84 17644065 10.1016/j.bbrc.2007.06.155 1:CAS:528:DC%2BD2sXotlWru7k%3D (Pubitemid 47102270)
22. MH Kulke EK Bergsland DP Ryan, et al. 2006 Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors J Clin Oncol 24 3555 3561 16877721 10.1200/JCO.2006.05.6762 1:CAS:528:DC%2BD28XovVSjs7o%3D (Pubitemid 46630526)
23. N Weidner 1995 Intratumor mocrovessel density as a prognostic factor in cancer Am J Pathol 147 9 19 7541613 1:STN:280:DyaK2MzivVKhtA%3D%3D
24. PB Vermeulen G Gasparini SB Fox, et al. 2002 Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumors Eur J Cancer 38 1564 1579 12142044 10.1016/S0959-8049(02)00094-1 1:STN:280:DC%2BD38zptlyjsQ%3D%3D (Pubitemid 34876495)
25. SB Fox 1997 Tumor angiogenesis and prognosis Histopathology 30 294 301 9088964 10.1046/j.1365-2559.1997.d01-606.x 1:STN:280:DyaK2s3ksVWmtw%3D%3D
26. M Bellomi S Viotti L Preda, et al. 2010 Perfusion CT in solid body-tumours. Part II: clinical applications and future development Radiol Med 115 6 858 874 20221706 10.1007/s11547-010-0545-9 1:STN:280: DC%2BC3cfoslyqug%3D%3D
27. R Avinash, et al. 2009 Body perfusion CT: technique, clinical applications, and advances Radiol Clin North Am 47 161 178 10.1016/j.rcl.2008. 11.003
28. DV Sahani NS Holalkere PR Mueller AX Zhu 2007 Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience Radiology 243 736 743 17517931 10.1148/radiol.2433052020 (Pubitemid 46799427)
29. HP Wu GS Feng HM Liang, et al. 2004 Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats World J Gastroenterol 10 813 818 15040023 1:CAS:528: DC%2BD2cXjtl2htbo%3D
30. A Maataoui J Qian D Vossoughi, et al. 2005 Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model Eur Radiol 15 1 127 133 15580507 10.1007/s00330-004-2517-8 1:STN:280:DC%2BD2M%2FitFSgug%3D%3D (Pubitemid 40109781)
31. AC Piguet D Semela A Keogh, et al. 2008 Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma J Hepatol 49 1 78 87 18486258 10.1016/j.jhep.2008.03.024 1:CAS:528:DC%2BD1cXmvFels7c%3D
32. ZX Kan S Phongkitkarun S Kobayashi, et al. 2005 Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model Radiology 237 151 158 16183931 10.1148/radiol.2363041293 (Pubitemid 41346159)
33. RS Kerbel 2006 Antiangiogenic therapy: a universal chemosenitizatin strategy for cancer? Science 312 1171 1175 16728631 10.1126/science.1125950 1:CAS:528:DC%2BD28XkvVOiur8%3D (Pubitemid 43801134)
34. RK Jain 2001 Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy Nat Med 7 987 989 11533692 10.1038/nm0901-987 1:CAS:528:DC%2BD3MXmvFOmsrc%3D (Pubitemid 32937367)
35. RT Poon IO Ng C Lau, et al. 2001 Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study Ann Surg 233 227 235 11176129 10.1097/00000658-200102000-00012 1:STN:280: DC%2BD3M7ls1SmsQ%3D%3D (Pubitemid 32106077)
36. M Wintermark JP Thiran P Maeder P Schnyder R Meuli 2001 Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study Am J Neuroradiol 22 905 914 11337336 1:STN:280: DC%2BD3MzotlGrtw%3D%3D (Pubitemid 32436235)
37. A Hakimé H Peddi AU Hines-Peralta, et al. 2007 CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model Radiology 243 712 719 17517930 10.1148/radiol.2433052048 (Pubitemid 46799424)
38. Z Kan S Kobayashi S Phongkitkarun C Charnsangavej 2005 Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model Radiology 237 144 150 16183930 10.1148/radiol.2371040526 (Pubitemid 41346158)
39. CJ Yoon JW Chung JH Park, et al. 2003 Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor Radiology 229 126 131 12944599 10.1148/radiol.2291021029 (Pubitemid 37152114)
40. 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor J Vasc Interv Radiol 15 1121 1128 15466799